James R. Baker Jr., M.D., is CEO of Food Allergy Research & Education (FARE) and the Ruth Dow Doan Professor at the University of Michigan.


Health Lab
Mylan took advantage of the US pharmaceutical industry to raise EpiPen costs and maximize profits. See the issues Mylan's epinephrine auto-injector surfaced.